Precise Infliximab Exposure and Pharmacodynamic Control
Condition:   Crohn Disease Interventions:   Device: RoadMAB;   Drug: Infliximab Sponsors:   Children's Hospital Medical Center, Cincinnati;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials